| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/20/2002 | US6436627 Gene encoding an invertebrate α1 calcium channel subunit |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436409 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | US6436407 E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity |
| 08/20/2002 | US6436405 Haemophilis influenzae vaccine |
| 08/20/2002 | US6436403 Pharmaceutical composition of the intercellular adhesion molecule ICAM-1 for use in anti-viral prophylactic therapy |
| 08/20/2002 | US6436400 Protease-activated receptor PAR4 ZCHEMR2 |
| 08/20/2002 | US6436399 Nucleic acid encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof |
| 08/20/2002 | US6436392 Dna segment confers increased episomal stability, persistence or abundance of the isolated dna molecule in a host cell |
| 08/20/2002 | US6436389 Stimulation of cell proliferation by glycosylated cystatin C |
| 08/20/2002 | US6436387 Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 08/20/2002 | CA2340475C Orphan receptor |
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2165678C Plants having modified response to ethylene |
| 08/20/2002 | CA2111340C Novel polypeptides and their use |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/20/2002 | CA1341385C Mutation of human granulocyte colony stimulating factor to allow the addition of carbohydrate chains at novel positions |
| 08/20/2002 | CA1341384C Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav |
| 08/15/2002 | WO2002063307A2 Methods of assessing wolframin protein activity |
| 08/15/2002 | WO2002063047A1 Novel molecules of the card-related protein family and uses thereof |
| 08/15/2002 | WO2002063021A2 Nucleotide sequence mediating male fertility and method of using same |
| 08/15/2002 | WO2002063019A2 Methods for generating resistance against cgmmv in plants |
| 08/15/2002 | WO2002063018A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | WO2002063017A2 Integrin-binding chimeras |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063011A1 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 08/15/2002 | WO2002063009A2 Lp mammalian proteins; related reagents |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002063003A2 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 08/15/2002 | WO2002063002A2 Novel human transporter protein and polynucleotides encoding the same |
| 08/15/2002 | WO2002063001A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/15/2002 | WO2002063000A2 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062998A1 Novel protein and dna thereof |
| 08/15/2002 | WO2002062997A1 Novel protein and use thereof |
| 08/15/2002 | WO2002062996A1 Novel physiologically active peptide and use thereof |
| 08/15/2002 | WO2002062995A2 Human dorsal root receptor-like g protein-coupled receptor |
| 08/15/2002 | WO2002062994A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | WO2002062959A2 Hepatitis b virus treatment |
| 08/15/2002 | WO2002062958A2 Prc17: an amplified cancer gene |
| 08/15/2002 | WO2002062957A2 Ter sites and ter binding proteins |
| 08/15/2002 | WO2002062955A2 Dendritic enriched secreted lymphocyte activation molecule |
| 08/15/2002 | WO2002062953A2 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 08/15/2002 | WO2002062952A2 Non-cytotoxic pap mutants |
| 08/15/2002 | WO2002062947A2 Hematopoietic growth factor inducible neurokinin-1 gene |
| 08/15/2002 | WO2002062946A2 Identification of novel ms4a gene family members expressed by hematopoietic cells |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062944A2 Novel physiologically active peptide and use thereof |
| 08/15/2002 | WO2002062852A1 Receptor protein expressed on cells |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062849A2 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/15/2002 | WO2002062848A2 Regulation of cc chemokine receptor 3 (ccr3) expression |
| 08/15/2002 | WO2002062847A2 Superficial zone protein and methods of making and using same |
| 08/15/2002 | WO2002062846A2 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | WO2002062845A2 Adhesion molecules |
| 08/15/2002 | WO2002062844A2 Long lasting growth hormone releasing factor derivatives |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062839A2 Markers of unstable atherosclerotic plaques |
| 08/15/2002 | WO2002062838A1 Binding domain of siah (seven in absentia homolog) protein |
| 08/15/2002 | WO2002062837A2 Cells with enhanced pkr expression for increasing cytokine production |
| 08/15/2002 | WO2002062836A2 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 08/15/2002 | WO2002062835A1 Nucleic acids and polypeptides for controlling food intake and/or body weight |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062833A2 Modified leptin with reduced immunogenicity |
| 08/15/2002 | WO2002062832A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | WO2002062831A1 Novel peptides, derivatives thereof, process for producing the same, novel strains producing the same and antiviral agents containing the same as the active ingedient |
| 08/15/2002 | WO2002062827A2 Improved protein disaggregation and refolding using high pressure |
| 08/15/2002 | WO2002062823A2 Peptides for facilitating composite receptor expression and translocation of macromolecules |
| 08/15/2002 | WO2002062822A2 Methods of identifying regulator molecules |
| 08/15/2002 | WO2002062819A2 Backbone cyclized radiolabelled somatostatin analogs |
| 08/15/2002 | WO2002062730A2 Thermodynamic propensities of amino acids in the native state ensemble: implications for fold recognition |
| 08/15/2002 | WO2002062381A1 Baculovirus vector vaccine |
| 08/15/2002 | WO2002062380A2 Chlamydia vaccine composition |
| 08/15/2002 | WO2002062379A2 Clostridium difficile vaccine |
| 08/15/2002 | WO2002062378A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | WO2002062375A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | WO2002062374A2 Muc1 isolation from bovine milk and whey |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002062369A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | WO2002062368A2 Method of inducing a ctl response |
| 08/15/2002 | WO2002062297A2 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | WO2002062296A2 Methods and compositions useful for stimulating an immune response |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |